DC
dRx Capital
Micro VCModeratedRx Capital AG is a joint venture investment company launched by Novartis and Qualcomm
9
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for dRx Capital.
Investment Thesis & Strategy
dRx Capital, a micro-VC backed by Novartis and Qualcomm, invests in various stages of fintech companies, leveraging its partners' expertise in healthcare and technology to identify and support innovative solutions.
Investment Activity
Deals per year over the last 8 years
1
20141
20150
20160
20170
20183
20190
20202
2021Portfolio Companies
Selected investments from their portfolio of 9 companies
T
Tessera Therapeutics
Biotech · Series B, 2021
G
GentiBio
Biotech · Series A, 2021
S
Sana Biotechnology
Biotech · Series A, 2019
C
Cellarity
Biotech · Series B, 2019
L
Lyell Immunopharma
Biotech · Series B, 2019
R
Revolution Medicines
Biotech · Series A, 2015
K
Kura Oncology
Biotech · Series A, 2014
Frequently Asked Questions
dRx Capital focuses on Seed, Series A stage investments.
Related Investors
Mesa Verde Venture Partners
San Diego, United States · 22 deals
Torrey Pines Investment
San Diego, United States · 20 deals
FusionX Ventures
San Diego, United States · 10 deals
eVisibility
San Diego, United States · 1 deals
Canter Capital
San Diego, United States · 1 deals
Greatscale Ventures
San Diego, United States · 1 deals